A high-payroll Mets team failed to contend in 2026. The club ended the year selling at the deadline but finished the season with signs of promise: a positive second half, emerging young players, and frontline salaries that create winter roster decisions.
2026 was a disappointment: Mets opened with a $355M cash payroll, fell out of contention, and became sellers at the trade deadline.
There are young pieces and momentum: Carson Benge, Nolan McLean, Zac Thornton, A.J. Ewing and Christian Scott all had notable rookie or comeback seasons, and the club went 34-31 after the break.
Big guaranteed money constrains decisions: Juan Soto ($596.25M to 2039), Francisco Lindor ($160M to 2031), and other multi-year contracts leave the Mets with $229.25M committed for 2027 and roughly $993M in total future obligations.
# Short summary
The Mets entered 2026 with championship plans and the highest payroll in MLB, but the season collapsed and the club sold at the trade deadline. Still, the second half produced worthwhile results: the team went 34-31, a group of young players made tangible progress, and manager Andy Green earned a three-year extension after taking over midseason.
# Payroll and guaranteed contracts
Opening Day cash payroll was about $355 million, roughly $40 million higher than the Dodgers that day. Major long-term contracts include Juan Soto ($596.25 million through 2039, with an opt-out after 2029 that the Mets can negate), Francisco Lindor ($160 million through 2031), and Bo Bichette ($84 million through 2028, with opt-out windows after 2026 or 2027 and a $5 million buyout). The team projects $229.25 million in financial commitments for 2027 and about $992.75 million in total future commitments.
Other guaranteed deals: Marcus Semien, Devin Williams, Sean Manaea, Jorge Polanco, Kodai Senga (with a conditional 2028 club option), and catcher Luis Torrens are all on multiyear deals.
# Roster status and arbitration
Arbitration-eligible players include Tylor Megill, Francisco Alvarez, Nolan McLean's peers (listed names include Cionel Pérez, Christopher Morel, Reed Garrett, Austin Warren, Mark Vientos, Brett Baty and others). The team has non-tender candidates among that group (Pérez, Morel, Vientos, Pache). Several minor-league–eligible players are free agents or will be soon.
# What went wrong and what went right in 2026
# Key offseason decisions
# Bottom line
The Mets’ rotation was one of the worst in MLB this season, sitting 23rd with a 4.47 ERA, 22nd with 791 innings pitched and 24th with a 9.1% walk rate. Only four Mets pitchers reached 100 innings: Nolan McLean (179 2/3), Sean Manaea (150 2/3), Christian Scott (110) and Freddy Peralta (113 2/3), the latter […]
A promising start to the season was derailed by a franchise-record 12-game losing stream early in the summer. That led to another deadline spent doing more selling than buying, but the Marlins’ short-term outlook is increasingly bright thanks to some breakthrough performances in 2026. Guaranteed Contracts None Other Fi
1. SS Jefferson Rojas | 21 | AA | 2027 A lot of prospects stumble with their new organization after headlining a deadline deal, but Rojas hasn’t missed a beat with the Mets. He has, however, continued to play at Double-A despite spending 159 games there over the last two years. He’s been particularly good for Binghamto
The Reds plummeted down the standings after a strong April. They lost one of their top two starters to Tommy John surgery that’ll likely cost him all of 2027. Most of the rotation underperformed and the back half of the lineup was as bad as any in the league. There’s still elite high-end talent, but […]
The Mets avoided a historically bad season, but their late surge has raised more questions than answers about the roster and David Stearns.
The 2026 season is near completion. While many teams are laser-focused on their final push to either reach the postseason or secure a critical first-round bye, others are already looking ahead to the offseason and the 2027 campaign (and beyond). Following this year’s World Series, we’ll of course have our annual Top 50
Loading more related stories...
Open the app view to save this story, compare related coverage, and continue from the same source.